| 1/14 | US=11 / Quimioterapia Perry MC. The chemotherapy source book. 2 ed. Baltimore: Willians & Wilkins, 1996. 1518 p. ISBN 0-683-23019-0. NEOPLASIA; AGENTES ANTINEOPLASICOS; USO TERAPEUTICO; DROGAS; QUIMIOTERAPIA; QUIMIOTERAPEUTICOS; CANCER; TEAPIA COM DROGAS |
| 2/14 | US=12 / Dermatologia Fraker DL, Eggermont AMM. Hyperthermic regional perfusion for melanoma of the limbs. In: Balch CM, Houghton NA, Sober AJ, Soong S. Cutaneous melanoma. 4ªed. St. Louis: Quality Medical Publishing, 2003. p. 473-93. EPIDEMIOLOGIA; HISTORIA NATURAL; AGENTES QUIMIOTERAPEUTICOS; TECNICAS E ASPECTOS ISOLADOS |
| 3/14 | US=8 / Quimioterapia Chabner BA, Longo DL. Cancer chemotherapy and biotherapy: principles and practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2006. 879 p. ISBN 978-0-7817-5628-6. NEOPLASIA; QUIMIOTERAPIA; QUIMIOTERAPEUTICOS; CANCER; BIOTERAPIA |
| 4/14 | US=2 / Quimioterapia Chu E, DeVita VT. Physicians' cancer chemotherapy drug manual: 2010. Boston: Jones and Bartlett Publishers, 2010. 559 p. ISBN 978-0-7637-8176-7. |
| 5/14 | US=14 / Quimioterapia Sievers TD, Andam R, Madsen L. Chemotherapy administration and immediate postdministration issues. In: Kline N. The pediatric chemotherapy and biotherapy curriculum. 2ªed. Glenview: APHON, 2009. p. 67-88. ISBN 978-09666193-17. ADMINISTRACAO DE QUIMIOTERAPIA; AVALIACAO DE ENFERMAGEM; AVALIAR TIPOS ESPECIFICOS DE PACIENTES; INTERVENCOES DE ENFERMAGEM; ADMINISTRACAO DE QUIMIOTERAPIA; ADMINISTRACAO DE QUIMIOTERAPIA; VIAS DE ADMINISTRACAO; METODOS DE INFUSAO; SEQUENCIA DE AGENTES QUIMIOTERAPEUTICOS; HORARIOS DE ADMINISTRACAO; MONITORIZACAO DOS EFEITOS COLATERAIS E COMPLICACOES; QUIMIOTERAPIA ELIMINACAO DE RESIDUOS; ESPERA OS RESULTADOS |
| 6/14 | US=8 / Laboratório Gerson SL, Bhalla KN, Grant S, Natarajan K, Creger RJ, DeRemer D. Pharmacology and molecular mechanisms of antineoplastic agents for hematologic malignancies. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Silberstein LE, McGlave P, Heslop HE. Hematology: basic principles and practice. 5th ed. Philadelphia: Churchill Livingstone, 2009. p. 839-98. ISBN 978-0-443-06715-0. FARMACOLOGIA; MECANISMOS MOLECULARES; AGENTES ANTINEOPLASICOS; DOENCAS HEMATOLOGICAS; CINETICA CELULAR; CICLO CELULAR; CRESCIMENTO DO TUMOR; AGENTES QUIMIOTERAPEUTICOS; APOPTOSE; RESISTENCIA A DROGAS; AGENTES ALQUILANTES; AGENTES ANTIMICROTUBULOS; ANTIMETABOLITOS; INIBIDORES DA TOPOISOMERASE; ANALOGOS DE PLATINA |
| 7/14 | US=11-B / Quimioterapia Clamon GH. Extravasation. In: Perry MC. The chemotherapy source book. 4th ed. Philadelphia: Wolters Kluwer, 2008. p. 148-51. ISBN 978-0-7817-7328-7. EXTRAVASAMENTO DE AGENTES QUIMIOTERAPEUTICOS; MECANISMOS DE LESAO DO TECIDO; PREVENCAO |
| 8/14 | US=11-B / Quimioterapia Hanna NH. Chemotherapy of lung cancer. In: Perry MC. The chemotherapy source book. 4th ed. Philadelphia: Wolters Kluwer, 2008. p. 341-62. ISBN 978-0-7817-7328-7. QUIMIOTERAPIA; CANCER DE PULMAO; CANCER DE PULMAO DE CELULAS PEQUENAS; QUIMIOTERAPEUTICOS; CANCER DE PULMAO DE CELULAS NAO-PEQUENAS |
| 9/14 | US=30-A / Câncer Peters B. Dose adjustments of commonly used chemotherapeutic agents in hepatic failure and renal failure. In: Govindan R. The Washington manual of oncology. 2 nd. Philadelphia: J.B. Lippincott, 2008. p. 492-6. ISBN 978-1-5889-0323-0. AGENTES QUIMIOTERAPEUTICOS VULGARMENTE; INSUFICIENCIA HEPATICA; RENAL |
| 10/14 | US=30-A / Câncer Kurtzeborn CM, Hlandnik LM, Augustin KM. Selected chemotherapeutic regimens. In: Govindan R. The Washington manual of oncology. 2 nd. Philadelphia: J.B. Lippincott, 2008. p. 497-533. ISBN 978-1-5889-0323-0. |
| 11/14 | US=39 / Câncer Sorokin A. Eicosanoids and resistance of cancer cells to chemotherapeutic agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 133-56. ISBN 978-1-58829-989-5. EICOSANOIDES; RESISTENCIA DAS CELULAS CANCEROSAS; AGENTES QUIMIOTERAPEUTICOS; SINTESE CELULAR DE EICOSANOIDES; ACIDO ARAQUIDONICO |
| 12/14 | US=55 / Biol/Mol Gumina G, Chong Y, Chu CK. L-nucleosides as chemotherapeutic agents. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 173-98. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5. L-NUCLEOSIDEOS; AGENTES QUIMIOTERAPEUTICOS; AGENTES ANTICANCERIGENOS; AGENTES ANTIVIRAIS; DEOXICITIDINA QUINASE; L-NUCLEOSIDES; TROXACITABINA; LAMIVUDINA; EMTRICITABINA; TELBIVUDINA; VALTORCITABINE; CLEVUDINE; ELVUCITABINE |
| 14/14 | US=22-C / Câncer Copur MS, Gettinger SN, Goldberg SB, Deshpande HA. Agentes quimioterapêuticos variados. In: DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 10 ed. Philadelphia: Wolters Kluwer, 2015. p. 267-277. ISBN 978-1-45119294-0. HOMOHARRINGTONINA E OMACETAXINA; L-ASPARAGINASE; BLEOMICINA; PROCARBAZINA; VISMODEGIB; ADO-TRASTUZUMAB EMTANSINE; SIROLIMUS E TEMSIROLIMUS; EVEROLIMUS; LENALIDOMIDA; TALIDOMIDA; POMALIDOMIDA |